staurosporine has been researched along with enmd 2076 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gao, L; Li, J; Lu, W; Shen, Q; Tong, L; Zhang, Q | 1 |
| Fan, C; Fan, Y; Wang, D; Xu, Y; Yang, H; Yang, X; Yang, Y; Zhong, T | 1 |
2 other study(ies) available for staurosporine and enmd 2076
| Article | Year |
|---|---|
Pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives as new multi-targeted inhibitors of Aurora A/B and KDR.
Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Azepines; Cell Line, Tumor; Humans; Mice; Mice, Nude; Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition.
Topics: Antineoplastic Agents; Apoptosis; Aurora Kinase A; Benzimidazoles; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; Molecular Docking Simulation; Protein Binding; Protein Kinase Inhibitors; Quinazolinones | 2020 |